Q4 2024 · 13F-HR
Eagle Health Investments LPholdings as filed
Filed 2025-02-12 · accession 0001172661-25-000676
$407.9M
Reported value
18
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $53.8M | 13.2% | 339,764 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $46.1M | 11.3% | 74,990 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $45.9M | 11.2% | 343,361 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $43.9M | 10.8% | 209,190 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $35.5M | 8.69% | 513,700 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $27.6M | 6.75% | 419,212 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $26.4M | 6.47% | 627,600 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $25.3M | 6.21% | 136,603 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $21.4M | 5.23% | 274,551 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $21.2M | 5.19% | 155,000 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $18.8M | 4.60% | 233,089 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $17.9M | 4.40% | 76,256 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $10.9M | 2.67% | 330,830 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $7.7M | 1.89% | 21,802 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $2.3M | 0.56% | 4,390 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $1.4M | 0.33% | 46,300 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $1.1M | 0.28% | 18,061 | Common | SOLE |
| 384747101 | GRAL | GRAIL INC | $948,263 | 0.23% | 53,124 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.